“Grants can be mind-boggling,” said Anna Moore, PhD. “Even a simple R-01 is 150 pages. How do you justify what you’re asking money for? How much to ask for?”
In the newly created role of associate dean for research development, Moore will work with three groups of people to improve the quality and quantity of research grant applications submitted by faculty: young scientists still learning the art of grantsmanship, experienced scientists who hope to improve their chances of getting large, complex grants or develop their skills as a mentor, and scientists at all levels ready to transition their work into entrepreneurial opportunities.
“My goal is to lift us up,” Moore said. “To raise the level of scholarship in the institution, to brag about it, and to make everyone want to be part of our scientific discovery.”
Moore has experience developing rigorous research programs. She’s the founding director of the Precision Health Program, whose papers and grants have raised the national ranking of MSU’s Radiology Department to first in the Big Ten.
Having been a mentor for over 80 trainees, Moore is perhaps more proud of the work they have done under her guidance than she is about the $40 million in funding she’s raised for her own research.
“I love to work with young scientists,” she said. “They have such vibrant minds and have so many ideas, and I want to be able to help them direct it in a positive direction. You become more happy that your mentee got their grant than you would be about your own grant.”
Moore said that through the systems she’s developing to work at the foundation level with new scientists—and to build mentoring, grant-writing, and entrepreneurship skills across all levels of the college—the College of Human Medicine will realize both short- and long-term benefits.
“We’ll have a much better chance of recruiting high-profile faculty with funding from good institutions, and including medical students and graduate students at a much earlier time,” she said, adding that she envisions a college community so motivated by past and current research that future research and renown are all but secured.
“People land in the Lansing Airport, and they see a huge face of Sparty—which is good,” she said. “But it would also be nice to say, ‘Welcome to Lansing, home of Sparty. Welcome to Lansing, home of cisplatin.’”
Cisplatin, a widely used cancer drug, was developed by MSU biophysical chemist Barnett Rosenberg in the 1960s.
Leave a Comment
Last Updated: July 22, 2024 by Jennifer Bunge
Dr. Moore profiled for new role as Associate Dean of research development
“Grants can be mind-boggling,” said Anna Moore, PhD. “Even a simple R-01 is 150 pages. How do you justify what you’re asking money for? How much to ask for?”
“My goal is to lift us up,” Moore said. “To raise the level of scholarship in the institution, to brag about it, and to make everyone want to be part of our scientific discovery.”
Moore has experience developing rigorous research programs. She’s the founding director of the Precision Health Program, whose papers and grants have raised the national ranking of MSU’s Radiology Department to first in the Big Ten.
Having been a mentor for over 80 trainees, Moore is perhaps more proud of the work they have done under her guidance than she is about the $40 million in funding she’s raised for her own research.
“I love to work with young scientists,” she said. “They have such vibrant minds and have so many ideas, and I want to be able to help them direct it in a positive direction. You become more happy that your mentee got their grant than you would be about your own grant.”
Moore said that through the systems she’s developing to work at the foundation level with new scientists—and to build mentoring, grant-writing, and entrepreneurship skills across all levels of the college—the College of Human Medicine will realize both short- and long-term benefits.
“We’ll have a much better chance of recruiting high-profile faculty with funding from good institutions, and including medical students and graduate students at a much earlier time,” she said, adding that she envisions a college community so motivated by past and current research that future research and renown are all but secured.
“People land in the Lansing Airport, and they see a huge face of Sparty—which is good,” she said. “But it would also be nice to say, ‘Welcome to Lansing, home of Sparty. Welcome to Lansing, home of cisplatin.’”
Cisplatin, a widely used cancer drug, was developed by MSU biophysical chemist Barnett Rosenberg in the 1960s.
Category: News